-+ 0.00%
-+ 0.00%
-+ 0.00%

InnoCare Pharma Wins China Approval for Phase II/III Trial of TYK2 Inhibitor in Chronic Urticaria

Reuters·12/18/2025 01:48:50

Please log in to view news